FDA approves Janssen Biotech's STELARA; Boston Scientific leads GI/endoscopic device market & more: 7 GI company key notes

Here are seven updates on gastroenterology and endoscopy companies.

In an effort to expand its gastroenterology portfolio, Allergan plans to acquire Tobira Therapeutics for up to $1.69 billion.

The FDA approved STELARA, a Crohn's disease treatment developed by Janssen Biotech.

Boston Scientific is the leading competitor in the GI/endoscopic device market, followed by Olympus.

The Israeli medical device company MOTUS GI received FDA clearance for its Pure-Vu System.

Cantel Medical acquired endoscope reprocessing business assets from Vantage Endoscopy.

Surgical Endoscopy published the results of a three-year controlled trial concerning long-term chronic gastroesophageal reflux disease control after a transoral incisionless fundoplication procedure with EsophyX, a device developed by EndoGastric Solutions.

Takeda Pharmaceutical was named one of Working Mother magazine's "Working Mother 100 Best Companies."

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast